← Open Payments lookup

AGNES MARAMBA: Open Payments

NPI 1770158172 · KENT, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,642 in 131 payments from 18 companies in 2025. Trend: 2023 $3,253 · 2024 $2,785 · 2025 $3,642

Food & beverage: $3,531Education: $111
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.22$641
Teva Pharmaceuticals USA, Inc.18$547
ABBVIE INC.15$427
Neurocrine BioSciences, Inc.8$293
Vanda Pharmaceuticals Inc.8$289
Alkermes, Inc.12$286
Janssen Pharmaceuticals, Inc7$228
Axsome Therapeutics, Inc.9$206
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$137
Takeda Pharmaceuticals U.S.A., Inc.5$120

Products named: REXULTI, VRAYLAR, FANAPT, ARISTADA, INGREZZA, Auvelity, SPRAVATO, AUSTEDO XR.

Industry payments across WA — which companies pay providers there.